glp-1 molecular structure glucagon-like peptide 1 How GLP-1 Receptor Agonists Evolved

Our team includes experienced master artist injectors, and our providers experience spans: Heidi, PA-C (15 years), Alicia, PA-C (10 years), Katie, NP-BC (7 years), Joni, RN (5 years), Tiffany, PA-C (5 years)

Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction

The GLP-1 and alcohol connection may represent one of the most significant breakthroughs in addiction neuroscience in decades

Recognizing this potential, the FDA approved a higher-dose formulation under the brand name Wegovy specifically for chronic weight management, indicated for clients meeting certain Body Mass Index (BMI) criteria